Literature DB >> 27389009

Full and Partial Agonism of a Designed Enzyme Switch.

S Jimmy Budiardjo1, Timothy J Licknack1, Michael B Cory1, Dora Kapros1, Anuradha Roy1, Scott Lovell1, Justin Douglas1, John Karanicolas1.   

Abstract

Chemical biology has long sought to build protein switches for use in molecular diagnostics, imaging, and synthetic biology. The overarching challenge for any type of engineered protein switch is the ability to respond in a selective and predictable manner that caters to the specific environments and time scales needed for the application at hand. We previously described a general method to design switchable proteins, called "chemical rescue of structure", that builds de novo allosteric control sites directly into a protein's functional domain. This approach entails first carving out a buried cavity in a protein via mutation, such that the protein's structure is disrupted and activity is lost. An exogenous ligand is subsequently added to substitute for the atoms that were removed by mutation, restoring the protein's structure and thus its activity. Here, we begin to ask what principles dictate such switches' response to different activating ligands. Using a redesigned β-glycosidase enzyme as our model system, we find that the designed effector site is quite malleable and can accommodate both larger and smaller ligands, but that optimal rescue comes only from a ligand that perfectly replaces the deleted atoms. Guided by these principles, we then altered the shape of this cavity by using different cavity-forming mutations, and predicted different ligands that would better complement these new cavities. These findings demonstrate how the protein switch's response can be tuned via small changes to the ligand with respect to the binding cavity, and ultimately enabled us to design an improved switch. We anticipate that these insights will help enable the design of future systems that tune other aspects of protein activity, whereby, like evolved protein receptors, remolding the effector site can also adjust additional outputs such as substrate selectivity and activation of downstream signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27389009      PMCID: PMC5161622          DOI: 10.1021/acssynbio.6b00097

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  43 in total

Review 1.  NMR methods for the determination of protein-ligand dissociation constants.

Authors:  Lee Fielding
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

2.  Agonism/antagonism switching in allosteric ensembles.

Authors:  Hesam N Motlagh; Vincent J Hilser
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-02       Impact factor: 11.205

3.  Functional selectivity at GPCRs: new opportunities in psychiatric drug discovery.

Authors:  Steven D Chang; Michael R Bruchas
Journal:  Neuropsychopharmacology       Date:  2014-01       Impact factor: 7.853

Review 4.  NMR methods in fragment screening: theory and a comparison with other biophysical techniques.

Authors:  Claudio Dalvit
Journal:  Drug Discov Today       Date:  2009-08-27       Impact factor: 7.851

5.  A new era of GPCR structural and chemical biology.

Authors:  Sébastien Granier; Brian Kobilka
Journal:  Nat Chem Biol       Date:  2012-07-18       Impact factor: 15.040

6.  The interplay between effector binding and allostery in an engineered protein switch.

Authors:  Jay H Choi; Tina Xiong; Marc Ostermeier
Journal:  Protein Sci       Date:  2016-06-24       Impact factor: 6.725

7.  The designability of protein switches by chemical rescue of structure: mechanisms of inactivation and reactivation.

Authors:  Yan Xia; Nina DiPrimio; Theodore R Keppel; Binh Vo; Keith Fraser; Kevin P Battaile; Chet Egan; Christopher Bystroff; Scott Lovell; David D Weis; J Christopher Anderson; John Karanicolas
Journal:  J Am Chem Soc       Date:  2013-12-06       Impact factor: 15.419

8.  A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.

Authors:  Laura A Banaszynski; Ling-Chun Chen; Lystranne A Maynard-Smith; A G Lisa Ooi; Thomas J Wandless
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

9.  Fluorine-NMR experiments for high-throughput screening: theoretical aspects, practical considerations, and range of applicability.

Authors:  Claudio Dalvit; Paul E Fagerness; Daneen T A Hadden; Ronald W Sarver; Brian J Stockman
Journal:  J Am Chem Soc       Date:  2003-06-25       Impact factor: 15.419

10.  Structure of an engineered β-lactamase maltose binding protein fusion protein: insights into heterotropic allosteric regulation.

Authors:  Wei Ke; Abigail H Laurent; Morgan D Armstrong; Yuchao Chen; William E Smith; Jing Liang; Chapman M Wright; Marc Ostermeier; Focco van den Akker
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

View more
  2 in total

1.  Modulating Antibody Structure and Function through Directed Mutations and Chemical Rescue.

Authors:  Christine E Kaiser; Juan Pablo Rincon Pabon; Jittasak Khowsathit; M Paola Castaldi; Steven L Kazmirski; David D Weis; Andrew X Zhang; John Karanicolas
Journal:  ACS Synth Biol       Date:  2018-04-09       Impact factor: 5.110

2.  Computational Design of an Allosteric Antibody Switch by Deletion and Rescue of a Complex Structural Constellation.

Authors:  Jittasak Khowsathit; Andrea Bazzoli; Hong Cheng; John Karanicolas
Journal:  ACS Cent Sci       Date:  2020-03-11       Impact factor: 14.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.